S. Gail Eckhardt

Dr. Eckhardt has served on the Board of Directors of the American Society of Clinical Oncology (ASCO) as well as numerous committees and study sections, including the GI Steering Committee of the Southwest Oncology Group, the ASCO Molecular Oncology Task Force and the EORTC Early Clinical Trials Review Panel. She has served as Chair of the FDA’s Oncology Drug Advisory Committee and currently serves on the Colorectal Cancer Task Force and the Investigational Drug Steering Committee of the NCI. Dr. Eckhardt is the Principal Investigator on an NCI grant involving early clinical trials research and has conducted numerous phase I and II clinical trials. She has published over 170 manuscripts. Dr. Eckhardt received her medical degree from the University of Texas Medical Branch in Galveston, Texas, and her internship and residency at the University of Virginia Medical Center in Charlottesville. Her postgraduate training included a research fellowship in the Division of Experimental and Molecular Medicine at Scripps Clinic and Research Foundation, and a medical oncology and research fellowship at the University of California, San Diego School of Medicine. Prior to her move to The Dell Medical School, Dr. Eckhardt served as Professor of Medicine and Head of Medical Oncology at the University of Colorado Cancer Center. Dr. Eckhardt founded the Phase I Program at the University of Colorado Cancer Center in 1999 which enrolls over 200 cancer patients per year on trials of novel agents.